SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to ...

AI model reveals the structural secrets of misfolded proteins. A new artificial intelligence (AI) tool has provided critical ...

Researchers are looking for 200 healthy adults between 65 and 75 who have a close family member with dementia but who do not ...

Dementia — the progressive decline in cognitive abilities, impacting memory, language and reasoning — affects more than 6 million Americans and accounts for over 100,000 deaths each year.

People aged over 45 who needed acute hospital care due to heavy cannabis use had a 72% greater risk of developing dementia ...

The second U.S. drug shown to slow the progression of early Alzheimer's has arrived in Seattle-area clinics. One of the first ...

Can you kindly explain the differences between Alzheimer’ disease, dementia, cognitive impairment and memory loss?Raimi (by SMS) Dementia is a catch-all term and covers all types of brain problems.

Johnson, a family friend, visited the woman’s Port Hueneme home, where she lived with her daughter in February 2020, ...

HudsonAlpha launched a pilot study, Hope AD, to see how genetics and lifestyle influence a person’s risk of developing ...

Zahydie Burgos Ribot and her husband Francisco are working on completing their travel bucket list and spending quality time ...

Ralph Carmona, of Portland, who ran to raise awareness of the disease and the importance of federal research funds, finished ...